Company: CWAN
Filing Date: 2025-04-02
Form Type: 425
Source: 0001193125-25-071387
Chunk: 7

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-04-02
Form: 425
Chunk 7
---
 number of Enfusion Class A common stock and restricted stock units and Enfusion OpCo limited liability company units eligible to receive Merger Consideration (collectively, the “Eligible Shares”). The
“Aggregate Consideration” will be determined as the sum of (i) a number of shares of Clearwater Class A common stock equal to the product of (x) the Per Share Parent Stock Amount multiplied by (y) the total number of
Eligible Shares multiplied by (z) the Final Parent Stock Price and (ii) the product of $5.85 multiplied by the total number of Eligible Shares. The “Exchange Ratio” will be determined by dividing the Aggregate Consideration Per
Share by the Final Parent Stock Price.

Enfusion shareholders with questions regarding the election materials or the election process should contact
Innisfree M&A Incorporated, the information agent for the election, at (877) 750-0637 or their bank, broker or other nominee, as applicable, as soon as possible.

A more detailed description of the Merger Consideration and the proration procedures applicable to elections is contained in the Proxy Statement/Prospectus.
Enfusion stockholders are urged to read the Proxy Statement/Prospectus carefully and in its entirety. Copies of the Proxy Statement/Prospectus may be obtained free of charge by following the instructions below under “Additional Information and
Where to Find It.”

About Clearwater Analytics

Clearwater Analytics (NYSE: CWAN), a global, industry-leading SaaS solution, automates the entire investment lifecycle. With a single instance, multi-tenant
architecture, Clearwater offers award-winning investment portfolio planning, performance reporting, data aggregation, reconciliation, accounting, compliance, risk, and order management. Each day, leading insurers, asset managers, corporations, and
governments use Clearwater’s trusted data to drive efficient, scalable investing on more than $8.8 trillion in assets spanning traditional and alternative asset types. Additional information about Clearwater can be found atclearwateranalytics.com/?utm_medium=third-party&utm_source=press-release&utm_campaign=bw-enfusion_election_date.

About Enfusion

Enfusion’s investment management
software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one
system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over
850 investment managers